Showing 1 to 12 of 14 results
Substandard Cancer Drugs Found in Four African Countries
A study in The Lancet Global Health found that 17% of nearly 200 cancer drugs tested in hospitals and pharmacies across Ethiopia, Kenya, Malawi, and Cameroon had incorrect active ingredient levels, highlighting the need for improved pharmaceutical regulation and testing technologies in sub-Saharan A...
Substandard Cancer Drugs Found in Four African Countries
A study in The Lancet Global Health found that 17% of nearly 200 cancer drugs tested in hospitals and pharmacies across Ethiopia, Kenya, Malawi, and Cameroon had incorrect active ingredient levels, highlighting the need for improved pharmaceutical regulation and testing technologies in sub-Saharan A...
Progress
36% Bias Score
U.S. Investigates Pharmaceutical Supply Chain, Threatening Canadian Exports
The White House launched a national-security probe into the U.S. pharmaceutical supply chain, potentially imposing tariffs on over \$7 billion in Canadian pharmaceutical ingredient exports and impacting generic drugs, while also investigating semiconductor imports.
U.S. Investigates Pharmaceutical Supply Chain, Threatening Canadian Exports
The White House launched a national-security probe into the U.S. pharmaceutical supply chain, potentially imposing tariffs on over \$7 billion in Canadian pharmaceutical ingredient exports and impacting generic drugs, while also investigating semiconductor imports.
Progress
52% Bias Score
EU Faces Shortages of 16 Critical Medicines
The European Union is experiencing shortages of 16 critical medicines, impacting patient care across the bloc. These shortages result from manufacturing problems, increased demand, and manufacturer withdrawals, affecting antibiotics, insulin, cancer treatments, and vaccines.
EU Faces Shortages of 16 Critical Medicines
The European Union is experiencing shortages of 16 critical medicines, impacting patient care across the bloc. These shortages result from manufacturing problems, increased demand, and manufacturer withdrawals, affecting antibiotics, insulin, cancer treatments, and vaccines.
Progress
16% Bias Score
EU Proposes New Law to Tackle Medicine Shortages
The EU proposed a new Essential Medicines Act, including a mechanism prioritizing EU-produced medicines in public contracts to address medicine shortages, particularly antibiotics, insulin, and analgesics, by boosting domestic production and coordinated purchasing for scarce drugs, although concerns...
EU Proposes New Law to Tackle Medicine Shortages
The EU proposed a new Essential Medicines Act, including a mechanism prioritizing EU-produced medicines in public contracts to address medicine shortages, particularly antibiotics, insulin, and analgesics, by boosting domestic production and coordinated purchasing for scarce drugs, although concerns...
Progress
40% Bias Score
EU Ministers Propose Defense Funding for Critical Medicines Act
Eleven EU health ministers propose funding a new Critical Medicines Act through the EU defense budget to address Europe's pharmaceutical dependence on Asia (60-80%) and strengthen national security, leveraging the Rearm Europe plan's €800 billion.
EU Ministers Propose Defense Funding for Critical Medicines Act
Eleven EU health ministers propose funding a new Critical Medicines Act through the EU defense budget to address Europe's pharmaceutical dependence on Asia (60-80%) and strengthen national security, leveraging the Rearm Europe plan's €800 billion.
Progress
48% Bias Score
EU to Tackle Medicine Supply Chain Vulnerabilities with New Law
The European Commission will present a law on March 11th to reduce Europe's reliance on third countries for critical medicines, addressing supply chain vulnerabilities exposed by the COVID-19 pandemic and geopolitical tensions. The legislation aims to incentivize domestic production and improve acce...
EU to Tackle Medicine Supply Chain Vulnerabilities with New Law
The European Commission will present a law on March 11th to reduce Europe's reliance on third countries for critical medicines, addressing supply chain vulnerabilities exposed by the COVID-19 pandemic and geopolitical tensions. The legislation aims to incentivize domestic production and improve acce...
Progress
36% Bias Score
Substandard Cancer Drugs Found in Four African Countries
A study published in The Lancet Global Health found that 17% of nearly 200 cancer drugs sampled across hospitals and pharmacies in Ethiopia, Kenya, Malawi, and Cameroon contained incorrect active ingredient levels, highlighting a critical gap in pharmaceutical regulation and access to quality health...
Substandard Cancer Drugs Found in Four African Countries
A study published in The Lancet Global Health found that 17% of nearly 200 cancer drugs sampled across hospitals and pharmacies in Ethiopia, Kenya, Malawi, and Cameroon contained incorrect active ingredient levels, highlighting a critical gap in pharmaceutical regulation and access to quality health...
Progress
24% Bias Score
France: Amoxicillin Shortages Ease After Reduced Antibiotic Prescriptions
Following a decrease in antibiotic prescriptions for winter illnesses in France, amoxicillin supplies have normalized, with the ANSM reporting sufficient quantities to meet patient needs after shortages in 2022; however, some amoxicillin/clavulanic acid dosages remain limited, while clarithromycin s...
France: Amoxicillin Shortages Ease After Reduced Antibiotic Prescriptions
Following a decrease in antibiotic prescriptions for winter illnesses in France, amoxicillin supplies have normalized, with the ANSM reporting sufficient quantities to meet patient needs after shortages in 2022; however, some amoxicillin/clavulanic acid dosages remain limited, while clarithromycin s...
Progress
32% Bias Score
EU's Critical Medicines Act Unveiled Amidst Concerns Over Drug Shortages
The European Commission's Critical Medicines Act aims to tackle chronic drug shortages by overhauling procurement rules, promoting joint purchasing, and providing €88.5 million in subsidies, but faces criticism for insufficient funding and weak stockpiling measures.
EU's Critical Medicines Act Unveiled Amidst Concerns Over Drug Shortages
The European Commission's Critical Medicines Act aims to tackle chronic drug shortages by overhauling procurement rules, promoting joint purchasing, and providing €88.5 million in subsidies, but faces criticism for insufficient funding and weak stockpiling measures.
Progress
44% Bias Score
EU Critical Medicines Act Seeks to Address Pharmaceutical Supply Chain Vulnerabilities
The EU's Critical Medicines Act, to be released this week, aims to address Europe's vulnerability in pharmaceutical supply chains by mapping them, supporting domestic production, and diversifying sources, driven by the fact that 80–90% of the world's antibiotics are manufactured in Asia.
EU Critical Medicines Act Seeks to Address Pharmaceutical Supply Chain Vulnerabilities
The EU's Critical Medicines Act, to be released this week, aims to address Europe's vulnerability in pharmaceutical supply chains by mapping them, supporting domestic production, and diversifying sources, driven by the fact that 80–90% of the world's antibiotics are manufactured in Asia.
Progress
60% Bias Score
EU Ministers Push to Fund Essential Medicines via Defense Budget
Eleven EU health ministers urge integrating a proposed Critical Medicines Act into the EU's defense strategy, aiming to fund essential drug supplies using €800 billion from the "Rearm Europe" plan to address Europe's 60-80% reliance on Asia for pharmaceuticals.
EU Ministers Push to Fund Essential Medicines via Defense Budget
Eleven EU health ministers urge integrating a proposed Critical Medicines Act into the EU's defense strategy, aiming to fund essential drug supplies using €800 billion from the "Rearm Europe" plan to address Europe's 60-80% reliance on Asia for pharmaceuticals.
Progress
52% Bias Score
EU Rushes Critical Medicines Act, Bypassing Impact Assessment
The EU is rushing to pass the Critical Medicines Act by March 11th, to address medicine shortages, but will forgo an impact assessment, despite concerns from stakeholders about insufficient consultation and evidence gathering.
EU Rushes Critical Medicines Act, Bypassing Impact Assessment
The EU is rushing to pass the Critical Medicines Act by March 11th, to address medicine shortages, but will forgo an impact assessment, despite concerns from stakeholders about insufficient consultation and evidence gathering.
Progress
40% Bias Score
Showing 1 to 12 of 14 results